house · trading 2016-08-16 → 2016-08-19
*Notional-weighted price return on disclosed buys, marked to the latest close — open positions, per-share (share counts aren't disclosed, so this is price performance, not realized $ P&L).
| Date | Ticker | Type | Amount | Est. price | Latest close | Return |
|---|---|---|---|---|---|---|
| 2016-08-19 | GSK | BUY | $1K–$15K | $44.16 | $52.50 2026-06-26 | +18.9% |
| 2016-08-18 | GSK | BUY | $1K–$15K | $44.49 | $52.50 2026-06-26 | +18.0% |
| 2016-08-17 | GSK | BUY | $1K–$15K | $44.39 | $52.50 2026-06-26 | +18.3% |
| 2016-08-16 | GSK | BUY | $1K–$15K | $44.32 | $52.50 2026-06-26 | +18.5% |
Return: buys are marked to the latest close (open); sells tagged rt are realized round-trips vs a prior disclosed buy; exit = timing (how the stock moved after the sale, seller's perspective).
| Member | Shared tickers |
|---|---|
| Hon. Virginia Foxx | 1 · GSK |
| Hon. Kenny Marchant | 1 · GSK |
| Hon. Kurt Schrader | 1 · GSK |
| Hon. Mike Kelly | 1 · GSK |
| Hon. Fred Upton | 1 · GSK |
| Hon. James B. Renacci | 1 · GSK |
| Hon. John K. Delaney | 1 · GSK |
| Hon. Doug Lamborn | 1 · GSK |
| Hon. Peter Welch | 1 · GSK |
| Hon. Rohit Khanna | 1 · GSK |
| Hon. Roger W. Marshall | 1 · GSK |
| Hon. Bill Huizenga | 1 · GSK |